Hypomyelination with atrophy of basal ganglia and cerebellum

This code describes a rare, progressive neurodegenerative disorder characterized by the abnormal or reduced formation of myelin (hypomyelination) in the central nervous system, specifically affecting the basal ganglia and cerebellum. This leads to atrophy of these brain structures, resulting in a range of neurological impairments.

Assign this code for patients diagnosed with hypomyelination accompanied by documented atrophy of the basal ganglia and cerebellum. This diagnosis is typically established through neurological examination, genetic testing, and neuroimaging studies such as MRI demonstrating the characteristic brain abnormalities.

• Ensure documentation clearly specifies both hypomyelination and atrophy of the basal ganglia and cerebellum.
• Do not confuse with other leukodystrophies or isolated cerebellar atrophies without documented hypomyelination.
• Consider sequencing this code as the primary diagnosis when it is the main reason for the encounter, especially for diagnostic workups or management of this specific condition.